More people than ever are surviving cancer due to the development of targeted and effective treatments. Yet many cancer survivors are living with difficult and persistent side effects of these treatments, which can be incapacitating.
Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute
Associate Professor of Medicine, Indiana University School of Medicine
Walther Scholar in Psycho-Oncology, Indiana University School of Medicine
Adjunct Faculty, Department of Psychology, Purdue School of Science at IUPUI
Adjunct Faculty, Fairbanks Center for Medical Ethics
Board Certified Clinical Health Psychologist, Eskenazi Health Palliative Care Program
Member, Indiana University Simon Comprehensive Cancer Center
Dr. Shelley Johns’ patient-oriented research focuses on developing and evaluating integrative behavioral interventions to address common sources of suffering for adults with cancer that can be implemented in clinical practice. Specifically, her research focuses on: (1) improving the physical and psychological health of cancer survivors with lingering treatment-related symptoms (e.g., fatigue) and other common sources of distress (e.g., fear of cancer recurrence); and (2) enhancing quality of life for patients with terminal cancer and their family caregivers. Dr. Johns has been a leader in testing mindfulness-based interventions in cancer. Her research has been cited as supportive evidence for Mindfulness-Based Stress Reduction as a recommended treatment in clinical practice guidelines for fatigue by the National Comprehensive Cancer Network.
Since completing post-doctoral training in behavioral oncology research in 2012, Dr. Johns has led or co-led 10 clinical studies funded by the National Cancer Institute, Walther Cancer Foundation, IU Health, Indiana Clinical and Translational Sciences Institute, and Retirement Research Foundation.
Dr. Johns is a board-certified clinical health psychologist.
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
Role: Principal Investigator
This 3-arm randomized controlled trial will test the efficacy of group-based acceptance and commitment therapy compared to cognitive behavioral therapy and to enhanced usual care in breast cancer survivors with clinically significant fear of recurrence while examining its cost-effectiveness and the mechanisms by which the intervention may work.
Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer
The goal of this project is to test the efficacy of acceptance and commitment therapy compared to attention control in reducing fatigue interference in women with metastatic breast cancer.
Telephone Acceptance and Commitment Therapy Intervention for Caregivers (TACTICs) of Adults with Alzheimer’s Disease and Related Dementias: A Pilot Randomized Controlled Trial
Role: Co-Principal Investigator
The primary goal of this two-arm pilot randomized controlled trial is to assess feasibility, acceptability, and preliminary effects of telephone-based acceptance and commitment therapy for clinically anxious caregivers of adults with dementia compared to minimally enhanced usual care.
Reaching Our Colleagues: A Formative Study to Evaluate Approaches for Enhancing Wellness Among Health Care Providers at IU Health
(Indiana University Health)
The purpose of this mixed methods study is to evaluate strategies for participant engagement and outcome measurement that can be applied to future large-scale healthcare provider wellness programs.
Authors: Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, Tong Y, Wilhelm L, Carpenter JS, Von Ah D, Wagner CD, de Groot M, Schmidt K, Monceski D, Danh M, Alyea JM, Miller KD, Kroenke K